CN101579020A - Edible oil without saturated fatty acid - Google Patents
Edible oil without saturated fatty acid Download PDFInfo
- Publication number
- CN101579020A CN101579020A CNA2009100122027A CN200910012202A CN101579020A CN 101579020 A CN101579020 A CN 101579020A CN A2009100122027 A CNA2009100122027 A CN A2009100122027A CN 200910012202 A CN200910012202 A CN 200910012202A CN 101579020 A CN101579020 A CN 101579020A
- Authority
- CN
- China
- Prior art keywords
- acid
- edible oil
- saturated fatty
- fatty acid
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention provides edible oil without saturated fatty acid. The edible oil is characterized by comprising the following main ingredients by weight percentage: 75 to 90 percent of vegetable-oil acid, 8 to 20 percent of linoleic acid, and 2 to 5 percent of linolenic acid. The edible oil without the saturated fatty acid has the advantages of the following physiological functions: reducing serum cholesterase, triglyceride and low density lipoprotein, reducing blood viscosity, preventing formation of thrombus, promoting insulin beta-cell to secrete insulin, resisting the sensibility of a receptor to the insulin, providing strong functions of anticoagulation and hemangiectasis through transforming the edible oil into a precursor substance of male prostaglandin, namely prostacyclin, providing the edible oil without saturated fatty acid indispensable to a human body, playing certain effect in preventing high blood pressure, high blood fat, coronary heart disease and thrombosis and diabetes, synthesizing ficosapentenoic acid and docosahexenoic acid through reacting with relevant enzyme, and further playing roles in reducing blood fat and the like of the edible oil.
Description
Technical field
The present invention relates to edible oil.
Background technology
Along with the change of life style, hypertension, high fat of blood, diabetes, coronary heart disease, thrombotic disease have become the main threat of human health, and angiocardiopathy has become the first cause that causes Chinese's death.Patient crowd presents the trend of becoming younger.Except the medicine lipopenicillinase, how scientific and reasonable selection edible oil is a new problem that faces during we live.Primary condition is to reduce the intake of saturated aliphatic acid, cholesterol in the food.
World nutrition educational circles studies show that, bad " two-supremes two is low " phenomenon of ubiquity in the present edible oil, and promptly saturated fatty acid and linoleic acid (ω-6) are too high, and oleic acid (single saturated fatty acid that do not contain) and alpha-linolenic acid (ω-3) are low excessively.The oil of long-term edible this component ratio can produce very adverse influence to health.It is improper that edible oil is selected, and the absorption of aliphatic acid is unreasonable, may cause hypertension, high fat of blood, diabetes, cardiovascular and cerebrovascular diseases, obesity, depression, the generation of numerous diseases such as cancer.
Summary of the invention
The object of the present invention is to provide a kind of edible oil of correct proportioning aliphatic acid.
The invention provides a kind of edible oil that does not contain saturated fatty acid, it is characterized in that: main component is vegetable oil acid, linoleic acid and alpha-linolenic acid, and each composition percentage by weight is (75～90): (8～20): (2～5).
Oleic acid (C
18H
34O
2) (single do not contain saturated fatty acid) can reduce " low-density lipoprotein " (LDL-C) harmful content of cholesterol, can also significantly increase the useful content of cholesterol of " HDL " (H DL-C);
Linoleic acid (C
18H
32O
2) (single do not contain saturated fatty acid) be aliphatic acid essential on the animal physiological, belongs to ω-6 aliphatic acid;
Alpha-linolenic acid (C
18H
30O
2) (octatecatrienoic acid) be the aliphatic acid of needed by human, belongs to ω-3 type aliphatic acid.
The edible oil that does not contain saturated fatty acid provided by the invention can be added with in phytic acid, vitamin E, squalene, the pure and mild palmitoleic acid of octacosane one or more.
The edible oil that does not contain saturated fatty acid provided by the invention, its phytic acid (CH
3(CH
2)
27OH) content can be 0～10mg/100g main component, and phytic acid can improve the oxidation resistance several times to tens of times.
The edible oil that does not contain saturated fatty acid provided by the invention, the content of its vitamin E can be 60～200mg/100g main component, the physiologic function of vitamin E is the cleaning agent as free radical.
The edible oil that does not contain saturated fatty acid provided by the invention, the content of its squalene can be 100～700mg/100g main component, squalene has the function that similar red blood cell absorbs oxygen like that.
The edible oil that does not contain saturated fatty acid provided by the invention, the content of its n-octacosanol can be 20～50mg/100g main component, n-octacosanol has the muscle power of enhancing, endurance, energy, improve body reaction sensitivity, improve the physical stress ability, promote hormonal action, alleviate myalgia, improve myocardial function, lipopenicillinase reduces systolic blood pressure, improves the organism metabolism rate, reduce the effects such as generation of osteoporosis, become universally acknowledged antifatigue material.
The edible oil that does not contain saturated fatty acid provided by the invention, the content of its palmitic acid oil can be 200～1000mg/100g main component, and palmitic acid oil is to infant development, and pregnant woman and nursing women's early children development are grown up useful.
The edible oil that does not contain saturated fatty acid provided by the invention, its advantage is: have following physiological function:
1, reduces serum cholesterol, triglycerides and low-density lipoprotein (LDL-C);
2, reduce blood viscosity, prevent thrombosis;
3, promote insulin beta cell excreting insulin, by the sensitiveness of acceptor to insulin;
4, can change into the precursor substance prostacyclin of male prostate element in vivo, have very strong anti-freezing and vasorelaxation action;
5, do not contain saturated fatty acid for needed by human;
6, prevention hypertension, high fat of blood, coronary heart disease, thrombosis, diabetes there is certain effect;
Thereby 7, can synthesize eicosapentaenoic acid (EPA) and DHA (DHA), further bring into play it and reduce effects such as blood fat with corresponding enzyme reaction.
The specific embodiment
Embodiment 1
The edible oil main component that does not contain saturated fatty acid is vegetable oil acid 75g, linoleic acid 20g and alpha-linolenic acid 5g.
Embodiment 2
The edible oil main component that does not contain saturated fatty acid is vegetable oil acid 77.5g, linoleic acid 18g and alpha-linolenic acid 4.5g, is added with phytic acid 10mg, vitamin E 60mg.
Embodiment 3
The edible oil main component that does not contain saturated fatty acid is vegetable oil acid 80g, linoleic acid 16g and alpha-linolenic acid 4g, is added with phytic acid 10mg, vitamin E 60mg, squalene 100mg, n-octacosanol 20mg and palmitoleic acid 200mg.
Embodiment 4
The edible oil main component that does not contain saturated fatty acid is vegetable oil acid 82.5g, linoleic acid 14g and leukotrienes 3.5g, is added with phytic acid 10mg, vitamin E 80mg, squalene 250mg, n-octacosanol 27.5mg and palmitoleic acid 400mg.
Embodiment 5
The edible oil main component that does not contain saturated fatty acid is vegetable oil acid 85g, linoleic acid 12g and leukotrienes 3g, is added with phytic acid 10mg, vitamin e1 00mg, squalene 400mg, n-octacosanol 35mg and palmitoleic acid 600mg.
Embodiment 6
The edible oil main component that does not contain saturated fatty acid is vegetable oil acid 87.5g, linoleic acid 10g and leukotrienes 2.5g, is added with phytic acid 10mg, vitamin E2 00mg, squalene 700mg, n-octacosanol 50mg and palmitoleic acid 1000mg.
Embodiment 7
The edible oil main component that does not contain saturated fatty acid is vegetable oil acid 90g, linoleic acid 8g and leukotrienes 2g, is added with phytic acid 10mg, vitamin e1 60mg, squalene 550mg, n-octacosanol 42.5mg and palmitoleic acid 800mg.
Claims (7)
1, do not contain the edible oil of saturated fatty acid, it is characterized in that: main component is vegetable oil acid, linoleic acid and alpha-linolenic acid, and each composition percentage by weight is (75～90): (8～20): (2～5).
2, according to the described edible oil that does not contain saturated fatty acid of claim 1, it is characterized in that: be added with phytic acid, vitamin E, squalene but in alkanol and the palmitoleic acid one or more.
3, according to the described edible oil that does not contain saturated fatty acid of claim 2, it is characterized in that: the content of described phytic acid is 0～10mg/100g main component.
4, according to the described edible oil that does not contain saturated fatty acid of claim 2, it is characterized in that: the content of described vitamin E is 60～200mg/100g main component.
5, according to the described edible oil that does not contain saturated fatty acid of claim 2, it is characterized in that: the content of described squalene is 100～700mg/100g main component.
6, according to the described edible oil that does not contain saturated fatty acid of claim 2, it is characterized in that: the content of described n-octacosanol is 20～50mg/100g main component.
7, according to the described edible oil that does not contain saturated fatty acid of claim 1, it is characterized in that: the content of described palmitic acid oil is 200～1000mg/100g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2009100122027A CN101579020A (en) | 2009-06-24 | 2009-06-24 | Edible oil without saturated fatty acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2009100122027A CN101579020A (en) | 2009-06-24 | 2009-06-24 | Edible oil without saturated fatty acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101579020A true CN101579020A (en) | 2009-11-18 |
Family
ID=41361449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2009100122027A Pending CN101579020A (en) | 2009-06-24 | 2009-06-24 | Edible oil without saturated fatty acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101579020A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102172261A (en) * | 2011-03-09 | 2011-09-07 | 中国海洋大学 | Composition for constructing animal model of diabetes mellitus type II |
| CN105309634A (en) * | 2014-07-11 | 2016-02-10 | 马井芳 | Edible oil and bidirectional adjusting preparation technology thereof |
| CN105746736A (en) * | 2014-12-15 | 2016-07-13 | 丰益(上海)生物技术研发中心有限公司 | Oil composition for prolonging shelf life of foods |
| CN107048405A (en) * | 2017-03-03 | 2017-08-18 | 武汉锶博睿医药技术有限公司 | Aliphatic acid component microcapsules and preparation method thereof |
| CN113455553A (en) * | 2021-08-09 | 2021-10-01 | 金国祥 | Edible oil and preparation method thereof |
| CN116056694A (en) * | 2020-08-03 | 2023-05-02 | 富尔玛株式会社 | Digestive lipase activity inhibitor, inhibitor for increasing blood triglyceride concentration, and fat absorption inhibitor |
-
2009
- 2009-06-24 CN CNA2009100122027A patent/CN101579020A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102172261A (en) * | 2011-03-09 | 2011-09-07 | 中国海洋大学 | Composition for constructing animal model of diabetes mellitus type II |
| CN105309634A (en) * | 2014-07-11 | 2016-02-10 | 马井芳 | Edible oil and bidirectional adjusting preparation technology thereof |
| CN105746736A (en) * | 2014-12-15 | 2016-07-13 | 丰益(上海)生物技术研发中心有限公司 | Oil composition for prolonging shelf life of foods |
| CN107048405A (en) * | 2017-03-03 | 2017-08-18 | 武汉锶博睿医药技术有限公司 | Aliphatic acid component microcapsules and preparation method thereof |
| CN116056694A (en) * | 2020-08-03 | 2023-05-02 | 富尔玛株式会社 | Digestive lipase activity inhibitor, inhibitor for increasing blood triglyceride concentration, and fat absorption inhibitor |
| CN113455553A (en) * | 2021-08-09 | 2021-10-01 | 金国祥 | Edible oil and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103444911A (en) | Medicinal and edible health care blending oil | |
| CN101690526A (en) | Blend oil with proportional fatty acid prepared by walnut oil and other plant oils | |
| JP2019047817A (en) | Beverage composition for weight gain suppression, and method for weight gain suppression | |
| CN101579020A (en) | Edible oil without saturated fatty acid | |
| CN102232429A (en) | Novel health care oil | |
| CN102599270A (en) | Health flavoring oil being rich in alpha-linolenic acid and preparation method thereof | |
| CN103385493A (en) | Healthy food using Antarctic krill oil as main ingredient | |
| CN102742671A (en) | Nutrient plant blend oil | |
| CN103190619A (en) | Fish oil and linseed oil soft capsules and preparation method thereof | |
| CN102342330A (en) | Oil and fat composition containing diglyceride and use thereof | |
| CN100594804C (en) | Compound rhodamine oil soft capsule and method for preparing the same | |
| CN103053707A (en) | Preparation method of health-care composition for reducing blood fat | |
| CN105918497A (en) | Blend oil with healthcare function and preparation method thereof | |
| CN101558794A (en) | Composition with functions of lowering blood lipid and regulating blood sugar and preparation method thereof | |
| CN108271874A (en) | High DHA content antarctic krill oil reconciliation health-care oil and preparation method thereof | |
| CN101099562A (en) | Omega-3 unsaturated fatty acids appetizer oil and producing method and application thereof | |
| CN102106411B (en) | Nutrient oil for diabetics | |
| Choi et al. | Effect of intake of sponge gourd (Luffa cylindrica) seed oil and yukdomok (Chionanthus retusa L.) seed oil on lipid levels of blood and organs of a mice | |
| CN102232430A (en) | Health-care oil | |
| WO2022227149A1 (en) | Camellia oil and peony seed oil-based gelatin candy and preparation method therefor | |
| CN106176501A (en) | A kind of baby massage oil of gentleness | |
| CN110353056A (en) | A kind of edible vegetable blend oil | |
| CN108541768A (en) | A kind of torrid zone functional low grade fever amount coconut ready-mixed oil | |
| CN102488203A (en) | Soyasterol soft capsule | |
| CN104413169A (en) | Tea-seed oil-based fortified food balanced in omega-3, omega-6 and omega-9 fatty acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20091118 |